Page last updated: 2024-09-03

reboxetine and phosphotyrosine

reboxetine has been researched along with phosphotyrosine in 1 studies

Compound Research Comparison

Studies
(reboxetine)
Trials
(reboxetine)
Recent Studies (post-2010)
(reboxetine)
Studies
(phosphotyrosine)
Trials
(phosphotyrosine)
Recent Studies (post-2010) (phosphotyrosine)
6261931846,4754751

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Falcon, R; González, I; Jorquera, F; Monari, M; Orrego, F; Sandoval, M; Sandoval, S; Vargas, F; Wyneken, U1

Other Studies

1 other study(ies) available for reboxetine and phosphotyrosine

ArticleYear
Clinically relevant doses of fluoxetine and reboxetine induce changes in the TrkB content of central excitatory synapses.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:11

    Topics: Animals; Antidepressive Agents; Blotting, Western; Brain; Brain-Derived Neurotrophic Factor; Dose-Response Relationship, Drug; Fluoxetine; Glutamic Acid; Immunoprecipitation; Male; Morpholines; Phosphotyrosine; rab5 GTP-Binding Proteins; Rats; Rats, Sprague-Dawley; Reboxetine; Receptor, trkB; Subcellular Fractions; Synapses; Time Factors

2006